Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Safety & Effectiveness Evaluation of Seraph 100 in Treatment of Pts With COVID-19

NCT: NCT04547257 · ACTIVE_NOT_RECRUITING

NCT IDNCT04547257
StatusACTIVE_NOT_RECRUITING
Start Date2021-05-04
Completion2027-06-30

Brief Summary

Safety and Effectiveness Evaluation of Seraph 100 Microbind Affinity Blood Filter (Seraph 100) in the treatment of patients with COVID-19

Frequently Asked Questions

What is Safety & Effectiveness Evaluation of Seraph 100 in Treatment of Pts With COVID-19?

Safety & Effectiveness Evaluation of Seraph 100 in Treatment of Pts With COVID-19 is a clinical trial registered under NCT04547257. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04547257?

The current status of NCT04547257 (Safety & Effectiveness Evaluation of Seraph 100 in Treatment of Pts With COVID-19) is: ACTIVE_NOT_RECRUITING.

When did Safety & Effectiveness Evaluation of Seraph 100 in Treatment of Pts With COVID-19 start?

Safety & Effectiveness Evaluation of Seraph 100 in Treatment of Pts With COVID-19 started on 2021-05-04.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑